Spiral Therapeutics
Stub active Updated Apr 15, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
About
Spiral Therapeutics is a clinical-stage biotechnology company focused on developing novel therapies for inner ear disorders, including hearing loss and balance disorders 1. Its lead program, SPT-2101, delivered a statistically significant reduction of overall vertigo in patients with Meniere’s disease, and the company is preparing for a registrational clinical trial 1. Concurrent with the financing, Spiral announced a strategic R&D collaboration with Advanced Bionics to explore drug delivery at the time of cochlear implantation 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-04-14 | Series B | $27M | Gund Investment | Advanced Bionics, Ferring Ventures, Uni-Bio Science Group 1 |
What Investors Say
No verified investor quotes available at this time.
What Founders Say
No verified founder quotes available at this time.
Sources
-
PRNewsWire, “Spiral Therapeutics Announces $27 Million Series B Financing and Strategic Partnership with Advanced Bionics,” April 14, 2026. https://www.prnewswire.com/news-releases/spiral-therapeutics-announces-27-million-series-b-financing-and-strategic-partnership-with-advanced-bionics-302741713.html↩↩↩↩